In-situ cascade assembled peptide-drug conjugate for the treatment of bladder cancer by enhancing membrane-entry and lysosome destabilization.

Saved in:
Bibliographic Details
Title: In-situ cascade assembled peptide-drug conjugate for the treatment of bladder cancer by enhancing membrane-entry and lysosome destabilization.
Authors: Zhang P; Department of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150001, China; Department of Urology, Harbin Medical University Cancer Hospital, Harbin, 150001, China., Wu JC; Department of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150001, China; Department of Urology, Harbin Medical University Cancer Hospital, Harbin, 150001, China., Wang H; Faculty of Materials Science, Shenzhen MSU-BIT University, Shenzhen, 518115, China. Electronic address: wanghr@smbu.edu.cn., You HH; Department of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150001, China; Department of Urology, Harbin Medical University Cancer Hospital, Harbin, 150001, China., Wang DX; Department of PET-CT/MRI, 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, China., Jin JY; Department of PET-CT/MRI, 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, China., Duan HZ; Department of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150001, China., Li MS; Department of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150001, China., Li P; Department of PET-CT/MRI, 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, China., Wang K; Department of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150001, China., Tong ZC; Department of Urology, Harbin Medical University Cancer Hospital, Harbin, 150001, China., Guo PY; Department of Urology, Harbin Medical University Cancer Hospital, Harbin, 150001, China., Wang Z; Department of Urology, Harbin Medical University Cancer Hospital, Harbin, 150001, China. Electronic address: wangziqi@hrbmu.edu.cn., Zhao YB; Department of Urology, 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150001, China. Electronic address: zhaoyubo@hrbmu.edu.cn., Tang BZ; Guangdong Basic Research Center of Excellence for Aggregate Science, School of Science and Engineering, Chinese University of Hong Kong (Shenzhen), Longgang, Shenzhen, Guangdong, 518172, China. Electronic address: tangbenz@cuhk.edu.cn., Hou DY; Department of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150001, China. Electronic address: houdayong@hrbmu.edu.cn.
Source: Biomaterials [Biomaterials] 2026 Jun 27; Vol. 335, pp. 124405. Date of Electronic Publication: 2026 Jun 27.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8100316 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-5905 (Electronic) Linking ISSN: 01429612 NLM ISO Abbreviation: Biomaterials Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1878-5905
DOI:10.1016/j.biomaterials.2026.124405